194 related articles for article (PubMed ID: 15550471)
1. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.
Tilli MT; Reiter R; Oh AS; Henke RT; McDonnell K; Gallicano GI; Furth PA; Riegel AT
Mol Endocrinol; 2005 Mar; 19(3):644-56. PubMed ID: 15550471
[TBL] [Abstract][Full Text] [Related]
2. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.
Kuang SQ; Liao L; Wang S; Medina D; O'Malley BW; Xu J
Cancer Res; 2005 Sep; 65(17):7993-8002. PubMed ID: 16140972
[TBL] [Abstract][Full Text] [Related]
3. Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content.
Nakles RE; Shiffert MT; Díaz-Cruz ES; Cabrera MC; Alotaiby M; Miermont AM; Riegel AT; Furth PA
Mol Endocrinol; 2011 Apr; 25(4):549-63. PubMed ID: 21292825
[TBL] [Abstract][Full Text] [Related]
4. AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice.
Kuang SQ; Liao L; Zhang H; Lee AV; O'Malley BW; Xu J
Cancer Res; 2004 Mar; 64(5):1875-85. PubMed ID: 14996752
[TBL] [Abstract][Full Text] [Related]
5. Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity.
Reiter R; Oh AS; Wellstein A; Riegel AT
Oncogene; 2004 Jan; 23(2):403-9. PubMed ID: 14691461
[TBL] [Abstract][Full Text] [Related]
6. An isoform of the coactivator AIB1 that increases hormone and growth factor sensitivity is overexpressed in breast cancer.
Reiter R; Wellstein A; Riegel AT
J Biol Chem; 2001 Oct; 276(43):39736-41. PubMed ID: 11502741
[TBL] [Abstract][Full Text] [Related]
7. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-dependent and estrogen-independent mechanisms contribute to AIB1-mediated tumor formation.
Torres-Arzayus MI; Zhao J; Bronson R; Brown M
Cancer Res; 2010 May; 70(10):4102-11. PubMed ID: 20442283
[TBL] [Abstract][Full Text] [Related]
9. Expression and transactivating functions of the bZIP transcription factor GADD153 in mammary epithelial cells.
Talukder AH; Wang RA; Kumar R
Oncogene; 2002 Jun; 21(27):4289-300. PubMed ID: 12082616
[TBL] [Abstract][Full Text] [Related]
10. Igf1r is not required for AIB1-induced mammary hyperplasia and ductal branching.
Senoret V; Orlando L; Brunning J; Font de Mora J
Front Biosci (Elite Ed); 2012 Jun; 4(7):2536-45. PubMed ID: 22652659
[TBL] [Abstract][Full Text] [Related]
11. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene.
Torres-Arzayus MI; Font de Mora J; Yuan J; Vazquez F; Bronson R; Rue M; Sellers WR; Brown M
Cancer Cell; 2004 Sep; 6(3):263-74. PubMed ID: 15380517
[TBL] [Abstract][Full Text] [Related]
12. Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis.
Bagheri-Yarmand R; Talukder AH; Wang RA; Vadlamudi RK; Kumar R
Development; 2004 Jul; 131(14):3469-79. PubMed ID: 15226262
[TBL] [Abstract][Full Text] [Related]
13. Targeting the AIB1 oncogene through mammalian target of rapamycin inhibition in the mammary gland.
Torres-Arzayus MI; Yuan J; DellaGatta JL; Lane H; Kung AL; Brown M
Cancer Res; 2006 Dec; 66(23):11381-8. PubMed ID: 17145884
[TBL] [Abstract][Full Text] [Related]
14. ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance.
Louie MC; Zou JX; Rabinovich A; Chen HW
Mol Cell Biol; 2004 Jun; 24(12):5157-71. PubMed ID: 15169882
[TBL] [Abstract][Full Text] [Related]
15. Genetic ablation of the amplified-in-breast cancer 1 inhibits spontaneous prostate cancer progression in mice.
Chung AC; Zhou S; Liao L; Tien JC; Greenberg NM; Xu J
Cancer Res; 2007 Jun; 67(12):5965-75. PubMed ID: 17575167
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells.
Oh AS; Lahusen JT; Chien CD; Fereshteh MP; Zhang X; Dakshanamurthy S; Xu J; Kagan BL; Wellstein A; Riegel AT
Mol Cell Biol; 2008 Nov; 28(21):6580-93. PubMed ID: 18765637
[TBL] [Abstract][Full Text] [Related]
17. Differential interactions of specific nuclear factor I isoforms with the glucocorticoid receptor and STAT5 in the cooperative regulation of WAP gene transcription.
Mukhopadhyay SS; Wyszomierski SL; Gronostajski RM; Rosen JM
Mol Cell Biol; 2001 Oct; 21(20):6859-69. PubMed ID: 11564870
[TBL] [Abstract][Full Text] [Related]
18. The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice.
Fereshteh MP; Tilli MT; Kim SE; Xu J; O'Malley BW; Wellstein A; Furth PA; Riegel AT
Cancer Res; 2008 May; 68(10):3697-706. PubMed ID: 18483252
[TBL] [Abstract][Full Text] [Related]
19. AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.
O'Hara J; Vareslija D; McBryan J; Bane F; Tibbitts P; Byrne C; Conroy RM; Hao Y; Gaora PÓ; Hill AD; McIlroy M; Young LS
Clin Cancer Res; 2012 Jun; 18(12):3305-15. PubMed ID: 22550166
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
